830424229	830424229	CD	B-NP	O
|	|	NN	I-NP	O
OH	OH	NN	I-NP	O
|	|	NN	I-NP	O
02928689	02928689	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
250355	250355	CD	B-NP	O
|	|	CC	I-NP	O
2/22/1997	2/22/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
R/O	R/O	NNP	I-NP	I-protein
PULMONARY	PULMONARY	NNP	I-NP	I-protein
EMBOLUS	EMBOLUS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/22/1997	2/22/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/23/1997	4/23/1997	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
SIGNIFICANT	SIGNIFICANT	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

NON-HODGKIN	NON-HODGKIN	NNP	B-NP	O
'S	'S	NNP	I-NP	O
LYMPHOMA	LYMPHOMA	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HODGKIN	HODGKIN	NNP	B-NP	O
'S	'S	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
,	,	,	O	O
STATUS	STATUS	VBZ	B-VP	O
POST	POST	NN	B-NP	O
MECHLORETHAMINE	MECHLORETHAMINE	NN	I-NP	O
,	,	,	O	O
VINCRISTINE	VINCRISTINE	NN	B-NP	O
,	,	,	O	O
PROCARBAZINE	PROCARBAZINE	NN	B-NP	O
,	,	,	O	O
AND	AND	CC	O	O
PREDNISONE	PREDNISONE	NNP	B-NP	O
CHEMOTHERAPY	CHEMOTHERAPY	NNP	I-NP	O
TEN	TEN	NNP	I-NP	O
YEARS	YEARS	NNP	I-NP	O
AGO	AGO	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
TOTAL	TOTAL	NNP	I-NP	O
ABDOMINAL	ABDOMINAL	NNP	I-NP	O
HYSTERECTOMY	HYSTERECTOMY	NNP	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Three	Three	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Kayser	Kayser	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
African	African	JJ	I-NP	O
American	American	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
72	72	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
Hodgkin	Hodgkin	NN	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
MOPP	MOPP	NN	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
more	more	RBR	B-VP	O
recently	recently	RB	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
non-Hodgkin	non-Hodgkin	JJ	B-NP	O
's	's	POS	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
CHOP	CHOP	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
the	the	DT	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
until	until	IN	B-PP	O
developing	develop	VBG	B-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
fatigue	fatigue	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
three	three	CD	I-NP	O
to	to	TO	I-NP	O
four	four	CD	I-NP	O
day	day	NN	I-NP	O
period	period	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
July	July	NNP	B-NP	O
1997	1997	CD	I-NP	O
,	,	,	O	O
Ms.	Ms.	NNP	B-NP	O
Vanzile	Vanzile	NNP	I-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Oncology	Oncology	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
biliary	biliary	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
peripancreatic	peripancreatic	JJ	I-NP	O
mass	mass	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
subclavicular	subclavicular	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
node	node	NN	I-NP	O
.	.	.	O	O

Biopsy	Biopsy	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subclavicular	subclavicular	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
node	node	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
non-Hodgkin	non-Hodgkin	JJ	B-NP	O
's	's	POS	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
CHOP	CHOP	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
Adriamycin	Adriamycin	NN	B-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
Hodgkin	Hodgkin	NN	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
ten	ten	CD	B-NP	O
years	year	NNS	I-NP	O
previously	previously	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	O	O
serial	serial	JJ	B-NP	O
echocardiograms	echocardiogram	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
six	six	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
previous	previous	JJ	I-NP	O
three	three	CD	I-NP	O
cycles	cycle	NNS	I-NP	O
of	of	IN	B-PP	O
CHOP	CHOP	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
were	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peripancreatic	peripancreatic	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
then	then	RB	I-NP	O
oral	oral	JJ	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
,	,	,	O	O
subsequently	subsequently	RB	B-ADVP	O
,	,	,	O	O
three	three	CD	B-NP	O
more	more	JJR	I-NP	O
cycles	cycle	NNS	I-NP	O
of	of	IN	B-PP	O
CHOP	CHOP	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
near	near	JJ	B-NP	O
complete	complete	JJ	I-NP	O
remission	remission	NN	I-NP	O
by	by	IN	B-PP	O
gallium	gallium	NN	B-NP	O
scan	scan	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
persistent	persistent	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
mass	mass	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
detected	detect	VBN	I-VP	O
on	on	IN	B-PP	O
Computerized	Computerize	VBN	B-NP	O
Tomography	Tomography	NN	I-NP	O
scan	scan	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
after	after	IN	B-PP	O
five	five	CD	B-NP	O
cycle	cycle	NN	I-NP	O
of	of	IN	B-PP	O
CHOP	CHOP	NN	B-NP	B-protein
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
maximum	maximum	JJ	I-NP	O
Adriamycin	Adriamycin	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
460	460	CD	B-NP	O
mg/m2	mg/m2	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
restaged	restage	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
acute	acute	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
weekend	weekend	NN	I-NP	O
,	,	,	O	O
denying	deny	VBG	B-VP	O
any	any	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	I-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
light-headedness	light-headedness	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
activities	activity	NNS	I-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
becoming	become	VBG	B-VP	O
more	more	RBR	B-ADJP	O
tired	tire	VBN	I-ADJP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	O	O
wakening	waken	VBG	B-VP	O
up	up	RP	B-PRT	O
suddenly	suddenly	RB	B-ADVP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
feeling	feeling	NN	I-NP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Includes	Include	VBZ	B-VP	O
Non-Hodgkin	Non-Hodgkin	JJ	B-NP	O
's	's	POS	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
,	,	,	O	O
Hodgkin	Hodgkin	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
with	with	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
salpingo-oophorectomy	salpingo-oophorectomy	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Reveals	Reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
well-developed	well-developed	JJ	I-NP	O
,	,	,	I-NP	O
well-nourished	well-nourished	JJ	I-NP	O
elderly	elderly	JJ	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
speak	speak	VB	I-VP	O
complete	complete	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
difficulty	difficulty	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
140	140	CD	B-NP	O
;	;	:	O	O
respiration	respiration	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
32	32	CD	B-NP	O
to	to	TO	B-PP	O
36	36	CD	B-NP	O
.	.	.	O	O

Oxygen	Oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
neck	neck	NN	I-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
centimeters	centimeter	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
thyromegaly	thyromegaly	NN	I-NP	O
or	or	CC	I-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
was	be	VBD	B-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rhonchi	rhonchi	NN	I-NP	O
or	or	CC	I-NP	O
wheezes	wheeze	NNS	I-NP	O
were	be	VBD	B-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
tachycardic	tachycardic	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
S3	S3	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
:	:	:	O	O
Electrocardiogram	Electrocardiogram	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
sinus	sinus	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
at	at	IN	B-PP	O
130	130	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axes	ax	NNS	I-NP	O
and	and	CC	I-NP	O
intervals	interval	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
profile-7	profile-7	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
3.3	3.3	CD	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
unremarkable	unremarkable	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
LDH	LDH	NN	I-NP	O
.	.	.	O	O

Cholesterol	Cholesterol	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
243	243	CD	B-NP	O
and	and	CC	O	O
elevated	elevate	VBD	B-VP	O
triglyceride	triglyceride	NN	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
197	197	CD	B-NP	O
.	.	.	O	O

Complete	Complete	JJ	B-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
,	,	,	I-NP	O
600	600	CD	I-NP	O
;	;	:	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
39.9	39.9	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MCV	MCV	NN	I-NP	O
of	of	IN	B-PP	O
91.2	91.2	CD	B-NP	O
;	;	:	O	O
and	and	CC	O	O
platelet	platelet	NN	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
131	131	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
differential	differential	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
coags	coag	NNS	I-NP	O
are	be	VBP	B-VP	O
also	also	RB	B-ADVP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Problem	Problem	NN	B-NP	O
number	number	NN	I-NP	O
one	one	CD	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
upon	upon	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
causes	cause	VBZ	B-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
status	status	NN	I-NP	O
included	include	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
suspicion	suspicion	NN	I-NP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
cardiac	cardiac	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
mildly	mildly	RB	I-NP	O
enlarged	enlarge	VBN	I-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
moderately	moderately	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Estimated	Estimate	VBN	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Global	Global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
significant	significant	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
septal	septal	JJ	I-NP	O
and	and	CC	I-NP	O
inferior	inferior	JJ	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
noted	note	VBN	B-VP	O
is	be	VBZ	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
PA	PA	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
had	have	VBD	B-VP	O
little	little	JJ	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
taken	take	VBN	B-VP	O
on	on	RP	B-PRT	O
May	May	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
35	35	CD	I-NP	O
%	%	NN	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
hypokinesis	hypokinesis	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
markedly	markedly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
1997	1997	CD	I-NP	O
with	with	IN	B-PP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
67	67	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
regimen	regimen	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
start	start	VB	I-VP	O
diuresis	diuresis	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
supplements	supplement	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
still	still	RB	B-ADVP	O
reported	report	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
upon	upon	IN	B-PP	O
minor	minor	JJ	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
consultation	consultation	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
deterioration	deterioration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
deterioration	deterioration	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
toxicity	toxicity	NN	I-NP	O
of	of	IN	B-PP	O
Adriamycin	Adriamycin	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
an	an	DT	B-NP	O
abnormality	abnormality	NN	I-NP	O
identified	identify	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
May	May	NNP	I-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
echocardiogram	echocardiogram	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
rupture	rupture	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chordae	chordae	JJ	I-NP	O
tendineae	tendineae	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
little	little	JJ	B-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
from	from	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
June	June	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
February	February	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Ace	Ace	NNP	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
ionatrope	ionatrope	NN	B-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
potassium	potassium	NN	B-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
wasting	wasting	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
add	add	VB	I-VP	O
digoxin	digoxin	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
developing	develop	VBG	B-VP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
noninvasive	noninvasive	JJ	I-NP	O
examinations	examination	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
patent	patent	NN	B-NP	O
vasculature	vasculature	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
indication	indication	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
VQ	VQ	NN	I-NP	O
scan	scan	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
probability	probability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
the	the	DT	B-NP	O
obtaining	obtaining	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
VQ	VQ	NN	I-NP	O
scan	scan	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
heparin	heparin	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
stated	state	VBN	I-VP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
enalapril	enalapril	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Lasix	Lasix	NN	B-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
manage	manage	VB	I-VP	O
the	the	DT	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Adriamycin-induced	Adriamycin-induced	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
wasting	wasting	NN	I-NP	O
.	.	.	O	O

Serial	Serial	JJ	B-NP	O
profile-7s	profile-7	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
potassium	potassium	NN	B-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
were	be	VBD	B-VP	O
regularly	regularly	RB	I-VP	O
supplemented	supplement	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
daily	daily	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
potassium	potassium	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
showed	show	VBD	B-VP	O
marked	marked	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
actively	actively	RB	B-NP	O
reduction	reduction	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
Ace	Ace	NNP	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
warned	warn	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
needed	need	VBD	B-VP	O
to	to	TO	I-VP	O
watch	watch	VB	I-VP	O
her	her	PRP$	B-NP	O
salt	salt	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
low-salt	low-salt	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
Chinese	Chinese	JJ	I-NP	O
food	food	NN	I-NP	O
dinner	dinner	NN	I-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Vasotec	Vasotec	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
KCl	KCl	NN	B-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gransberry	Gransberry	NNP	I-NP	O
of	of	IN	B-PP	O
Lourdesko	Lourdesko	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Oncology	Oncology	NNP	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
TOD	TOD	NN	B-NP	O
RIGGIO	RIGGIO	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
EN41	EN41	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DEWEY	DEWEY	NNP	B-NP	O
N.	N.	NNP	I-NP	O
TORRENT	TORRENT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AN33	AN33	NNP	I-NP	O
IH306/8223	IH306/8223	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
09216	09216	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

HCKFUW25NG	HCKFUW25NG	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
8/18/97	8/18/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/30/97	3/30/97	CD	B-NP	O

